Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Interplay between Chromosomal β-Lactamase and the MexAB-OprM Efflux System in Intrinsic Resistance to β-Lactams inPseudomonas aeruginosa

Nobuhisa Masuda, Naomasa Gotoh, Chie Ishii, Eiko Sakagawa, Satoshi Ohya, Takeshi Nishino
Nobuhisa Masuda
Biological Research Laboratories, Sankyo Co., Ltd., Shinagawa-ku, Tokyo 140-8710, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naomasa Gotoh
Department of Microbiology, Kyoto Pharmaceutical University, Yamashina, Kyoto 607-8414, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chie Ishii
Biological Research Laboratories, Sankyo Co., Ltd., Shinagawa-ku, Tokyo 140-8710, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eiko Sakagawa
Biological Research Laboratories, Sankyo Co., Ltd., Shinagawa-ku, Tokyo 140-8710, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoshi Ohya
Biological Research Laboratories, Sankyo Co., Ltd., Shinagawa-ku, Tokyo 140-8710, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeshi Nishino
Department of Microbiology, Kyoto Pharmaceutical University, Yamashina, Kyoto 607-8414, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.43.2.400
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We investigated the role of chromosomal β-lactamase and the MexAB-OprM efflux system in intrinsic resistance to β-lactams inPseudomonas aeruginosa. Determination of the susceptibilities of a series of isogenic mutants with impaired production of the β-lactamase and the efflux system to 16 β-lactams including penicillins, cephems, oxacephems, carbapenems, and a monobactam demonstrated that the intrinsic resistance of P. aeruginosa to most of the β-lactams is due to the interplay of both factors.

Pseudomonas aeruginosa is a clinically significant pathogen with intrinsic resistance to various antimicrobial agents. Although this organism has an outer membrane with low permeability (1, 26), this alone does not adequately explain its intrinsic resistance (19, 20). An additional mechanism that interferes with access of the agents to their targets is suspected to exist. MexA-MexB-OprM (3, 14, 24), MexC-MexD-OprJ (23), and MexE-MexF-OprN (12) are multidrug efflux systems of P. aeruginosa. Each of these systems consists of three components. The MexAB-OprM system expressed in wild-type strains (5) contributes to the intrinsic resistance of P. aeruginosa to most β-lactams and many other structurally unrelated antimicrobial agents by actively extruding them out of the cells (21, 24). In fact, inactivation of this system by an artificial mutation causes hypersusceptibility to the agents in this bacterium (2, 6, 24). The chromosomal AmpC β-lactamase can also contribute to the intrinsic resistance ofP. aeruginosa to β-lactams by inactivating the agents via hydrolysis (19, 20). Although the respective contributions of the efflux system and β-lactamase have been well characterized, there is little information on the interplay between the two. Therefore, we determined the alterations in the susceptibility ofP. aeruginosa that accompany defects in the production of AmpC β-lactamase and the MexAB-OprM system using isogenic mutants from a laboratory strain, PAO1, and we discuss the interplay between the two resistance factors.

After constructing KG2504 (ampC::Ω Smr [22]) from PAO1 by an allelic exchange technique (8), KG2507 (ΔmexRAB-oprM ampC::Ω Smr [22]) was constructed from KG2504 by the same technique and was used as anampC and mexRAB-oprM double mutant. KG2239 (ΔmexRAB-oprM [7]) was also used as a MexAB-OprM-deficient mutant from PAO1. The AmpC β-lactamase activity in crude cell extracts was examined by spectrophotometric assay with 100 μM cephaloridine as a substrate as described previously (16). No production of AmpC β-lactamase was detected in the cultures of any of the strains tested. When the cells were treated with cefmetazole as an inducer at a concentration of one-fourth the MIC for 1 h, PAO1 and KG2239 produced 0.3 to 0.6 U of β-lactamase per mg of protein, respectively, whereas KG2504 and KG2507 produced amounts of β-lactamase that were smaller than the detection limit. The production of MexAB-OprM was tested by an immunoblotting assay with TM001 (4), a murine monoclonal antibody specific to OprM encoded on the third gene of this operon. No OprM production was detected in KG2239 or KG2507 in the assay, although its production was apparent in PAO1 and KG2504 (data not shown). Thus, disruption of theampC gene and/or deletion of the mexAB-oprMoperon in KG2239, KG2504, and KG2507 were confirmed.

MICs were determined by the usual twofold agar dilution technique with Mueller-Hinton II agar (Becton Dickinson Microbiology Systems, Cockeysville, Md.) with an inoculum of 104 cells. Cefpodoxime, panipenem, and S-4661 (10) were synthesized at Sankyo Co., Ltd., Tokyo, Japan. The other antimicrobial agents used in this study were obtained from commercial sources. Table1 presents the MICs of 16 β-lactams for PAO1, KG2239, KG2504, and KG2507. The β-lactams included penicillins (carbenicillin, piperacillin, and amoxicillin), cephems (cefoperazone, cefsulodin, cefmetazole, cefpodoxime, cefuroxime, and ceftriaxone), oxacephems (flomoxef and moxalactam), carbapenems (panipenem, imipenem, meropenem, and S-4661), and a monobactam (aztreonam). All the β-lactams tested had potent activities against the AmpC- and MexAB-OprM-deficient double mutant KG2507, suggesting that they have high affinities for the penicillin-binding proteins of P. aeruginosa. In fact, although P. aeruginosa exhibits a higher level of resistance to carbenicillin, cefpodoxime, and moxalactam than Escherichia coli, the penicillin-binding proteins of P. aeruginosa, like those of E. coli, are inhibited by these agents at low concentrations (13, 25).

View this table:
  • View inline
  • View popup
Table 1.

Susceptibilities of PAO1 and its β-lactamase- and/or efflux system-deficient mutants to various β-lactams

The 16 β-lactams were grouped into the following three categories on the basis of the qualitative pattern of change in susceptibilities accompanying the deficiency of AmpC and/or MexAB-OprM. Group I consists of carbenicillin, piperacillin, cefoperazone, aztreonam, and cefsulodin. The loss of AmpC from PAO1 caused less than 2-fold increases in susceptibility to these agents, whereas the loss of MexAB-OprM from PAO1 caused 4- to 64-fold increases in susceptibility. Group II consists of amoxicillin, cefmetazole, flomoxef, panipenem, and imipenem. The loss of MexAB-OprM from PAO1 caused less than 2-fold increases in susceptibility to these agents, whereas the loss of AmpC from PAO1 caused 4- to 512-fold increases in susceptibility. Thus, in PAO1 the efflux system removes the group I agents from the periplasm more effectively than the β-lactamase does and the β-lactamase removes the group II agents from the periplasm more effectively than the efflux system does. Group III consists of cefpodoxime, cefuroxime, ceftriaxone, moxalactam, meropenem, and S-4661. The loss of either AmpC or MexAB-OprM alone from PAO1 did not cause any substantial change in susceptibilities to these agents, whereas the loss of both AmpC and MexAB-OprM from PAO1 caused remarkable increases in susceptibility to these agents. Thus, group III agents are equally removed from the periplasm by both the β-lactamase and the efflux system. The results obtained in this study are consistent with those obtained in another investigation with another series of OprM-deficient isogenic mutants derived from the AmpC-deficient strain PAO4089 (met-9020 pro-9024 blaJ9111 blaP9202; H. Matsumoto, Shinshu University) (17).

Most of the agents tested are known to be stabler against chromosomal β-lactamase of P. aeruginosa than the old cephems, e.g., cephaloridine (3, 18). However, the loss of AmpC from MexAB-OprM-deficient strain KG2239 caused a drastic increase in susceptibility to group II and III agents. Thus, a synergistic effect between the slow inactivation of these agents by the β-lactamase and low level of permeability of the outer membrane for these agents might contribute to this resistance. Moreover, a spontaneous mutant that constitutively produced the AmpC β-lactamase from PAO1 was 4 to 128 times more resistant to group I agents than its parent (17). Thus, the absence of any effect of the loss of AmpC on the susceptibilities to the group I agents may be due to the lower levels of AmpC inducibility by these agents rather than their higher AmpC stabilities.

The loss of either AmpC or MexAB-OprM from PAO1 caused little change in the susceptibilities to group III agents, suggesting that each removal mechanism contributes little to the intrinsic resistance to these agents individually. However, the loss of both AmpC and MexAB-OprM from PAO1 caused remarkable increases in the susceptibilities to these agents. These results show that either mechanism alone is almost sufficient to provide the wild-type level of resistance to group III agents, and both mechanisms contribute equally and powerfully to the removal of these agents from the periplasm. Thus, P. aeruginosa possesses redundant mechanisms for the removal of these agents.

We can explain the limitation in the change in susceptibilities to imipenem caused by the loss of AmpC and/or MexAB-OprM, although we cannot explain the limited change in susceptibilities to cefsulodin. To elucidate the former limitation we also isolated by the same technique a series of OprD-deficient isogenic mutants with impaired production of AmpC and/or MexAB-OprM (17). The loss of AmpC from PAO1 and MexAB-OprM-deficient strain KG2239 caused only fourfold increases in susceptibilities to imipenem, whereas the loss of AmpC from OprD-deficient strains caused 64-fold increases. Thus, in PAO1, the higher permeation of imipenem through the OprD outer membrane channel contributes to the limited change in susceptibilities to imipenem by the loss of AmpC.

Homologues of the MexAB-OprM efflux system are found in many species of gram-negative bacteria such as Neisseria gonorrhoeae(9), E. coli (15), Pseudomonas putida (11), Burkholderia cepacia(2), and Haemophilus influenzae (4). Thus, the interplay of double removal systems might be at work in a number of gram-negative bacteria.

ACKNOWLEDGMENTS

This research was partially supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan and by a grant from the Ministry of Health and Welfare of Japan.

We are grateful to K. Okamoto for providing strains KG2504 and KG2507.

FOOTNOTES

    • Received 29 July 1998.
    • Returned for modification 10 September 1998.
    • Accepted 9 November 1998.
  • Copyright © 1999 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Angus B. L.,
    2. Carey A. M.,
    3. Caron D. A.,
    4. Kropinski A. M. B.,
    5. Hancock R. E. W.
    Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob. Agents Chemother. 21 1982 299 309
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Burns J. L.,
    2. Wadsworth C. D.,
    3. Barry J. J.,
    4. Goodall C. P.
    Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob. Agents Chemother. 40 1996 307 313
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Chen H. Y.,
    2. Livermore D. M.
    In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms. J. Antimicrob. Chemother. 33 1994 949 958
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Fleischmann R. D.,
    2. Adams M. D.,
    3. White O.,
    4. Clayton R. A.,
    5. Kirkness E. F.,
    6. Kerlavage A. R.,
    7. Bult C. J.,
    8. Tomb J. F.,
    9. Dougherty B. A.,
    10. Merrick J. M.,
    11. McKenney K.,
    12. Sutton G.,
    13. FitzHugh W.,
    14. Fields C.,
    15. Gocayne J. D.,
    16. Scott J.,
    17. Shirley R.,
    18. Liu L.-I.,
    19. Glodek A.,
    20. Kelley J. M.,
    21. Weidmann J. F.,
    22. Phillips C. A.,
    23. Spriggs T.,
    24. Hedblom E.,
    25. Cotton M. D.,
    26. Utterback T. R.,
    27. Hanna M. C.,
    28. Nguyen L. D.,
    29. Saudek D. M.,
    30. Brandon R. C.,
    31. Fine L. D.,
    32. Fritchman J. L.,
    33. Geoghagen N. S. M.,
    34. Gnehm C. L.,
    35. McDonald L. A.,
    36. Small K. V.,
    37. Fraser C. M.,
    38. Smith H. O.,
    39. Venter J. C.
    Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269 1995 496 512
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Gotoh N.,
    2. Itoh N.,
    3. Tsujimoto H.,
    4. Yamagishi J.,
    5. Oyamada Y.,
    6. Nishino T.
    Isolation of OprM-deficient mutants of Pseudomonas aeruginosa by transposon insertion mutagenesis: evidence of involvement in multiple antibiotic resistance. FEMS Microbiol. Lett. 122 1994 267 274
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Gotoh N.,
    2. Tsujimoto H.,
    3. Poole K.,
    4. Yamagishi J.,
    5. Nishino T.
    The outer membrane protein OprM of Pseudomonas aeruginosa is encoded by oprK of the mexA-mexB-oprK multidrug resistance operon. Antimicrob. Agents Chemother. 39 1995 2567 2569
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Gotoh N.,
    2. Tsujimoto H.,
    3. Tsuda M.,
    4. Okamoto K.,
    5. Nomura A.,
    6. Wada T.,
    7. Nakahashi M.,
    8. Nishino T.
    Characterization of the MexC-MexD-OprJ multidrug efflux system in ΔmexA-mexB-oprM mutants of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42 1998 1938 1943
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Gotoh N.,
    2. Tsujimoto H.,
    3. Nomura A.,
    4. Okamoto K.,
    5. Tsuda M.,
    6. Nishino T.
    Functional replacement of OprJ by OprM in the MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 165 1998 21 27
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Hagman K. E.,
    2. Pan W.,
    3. Spratt B. G.,
    4. Balthazar T. J.,
    5. Judd R. C.,
    6. Shafer W. M.
    Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 141 1995 611 622
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Iso Y.,
    2. Irie T.,
    3. Nishino Y.,
    4. Motokawa K.,
    5. Nishitani Y.
    A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1 beta-methylcarbapenems. J. Antibiot. (Tokyo) 49 1996 199 209
    OpenUrlPubMed
  11. 11.↵
    1. Kieboom J.,
    2. Dennis J. J.,
    3. de Bont J. A. M.,
    4. Zylstra G. J.
    Identification and molecular characterization of an efflux pump involved in Pseudomonas putida S12 solvent tolerance. J. Biol. Chem. 273 1998 85 91
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Köler T.,
    2. Michéa-Hamzepour M.,
    3. Henze U.,
    4. Gotoh N.,
    5. Curty L. K.,
    6. Pechëre J.-C.
    Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23 1997 345 354
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Labia R.,
    2. Baron P.,
    3. Masson J.-M.
    Binding of latamoxef (moxalactam) and its decarboxylated derivative to Escherichia coli and Pseudomonas aeruginosa penicillin-binding proteins. J. Antimicrob. Chemother. 15 1985 9 15
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Li X.-Z.,
    2. Nikaido H.,
    3. Poole K.
    Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39 1995 1948 1953
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Ma D.,
    2. Cook D. N.,
    3. Hearst J. E.,
    4. Nikaido H.
    Efflux pumps and drug resistance in gram-negative bacteria. Trends Microbiol. 2 1994 489 493
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Masuda N.,
    2. Ohya S.
    Cross-resistance to meropenem, cephems, and quinolones Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36 1992 1847 1851
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Masuda, N., and N. Gotoh. Unpublished data.
  18. 18.↵
    1. Murata T.,
    2. Minami S.,
    3. Yasuda K.,
    4. Iyobe S.,
    5. Inoue M.,
    6. Mitsuhashi S.
    Purification and properties of cephalosporinase from Pseudomonas aeruginosa. J. Antibiot. (Tokyo) 34 1981 1164 1170
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Nikaido H.
    Role of permeability barriers in resistance to β-lactam antibiotics. Pharmacol. Ther. 27 1985 197 231
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Nikaido H.
    Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob. Agents Chemother. 33 1989 1831 1836
    OpenUrlFREE Full Text
  21. 21.↵
    1. Nikaido H.
    Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264 1994 382 388
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    Okamoto, K., N. Gotoh, H. Tsujimoto, and T. Nishino. Unpublished data.
  23. 23.↵
    1. Poole K.,
    2. Gotoh N.,
    3. Tsujimoto H.,
    4. Zhao Q.,
    5. Wada A.,
    6. Yamasaki T.,
    7. Neshat S.,
    8. Yamagishi J.,
    9. Li X.-Z.,
    10. Nishino T.
    Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21 1996 713 724
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Poole K.,
    2. Krebes K.,
    3. McNally C.,
    4. Neshat S.
    Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175 1993 7363 7372
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Yokota T.,
    2. Suzuki E.,
    3. Arai K.
    Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages. Drugs Exp. Clin. Res. 14 1988 495 500
    OpenUrlPubMed
  26. 26.↵
    1. Yoshimura F.,
    2. Nikaido H.
    Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. J. Bacteriol. 152 1982 636 642
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Interplay between Chromosomal β-Lactamase and the MexAB-OprM Efflux System in Intrinsic Resistance to β-Lactams inPseudomonas aeruginosa
Nobuhisa Masuda, Naomasa Gotoh, Chie Ishii, Eiko Sakagawa, Satoshi Ohya, Takeshi Nishino
Antimicrobial Agents and Chemotherapy Feb 1999, 43 (2) 400-402; DOI: 10.1128/AAC.43.2.400

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interplay between Chromosomal β-Lactamase and the MexAB-OprM Efflux System in Intrinsic Resistance to β-Lactams inPseudomonas aeruginosa
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Interplay between Chromosomal β-Lactamase and the MexAB-OprM Efflux System in Intrinsic Resistance to β-Lactams inPseudomonas aeruginosa
Nobuhisa Masuda, Naomasa Gotoh, Chie Ishii, Eiko Sakagawa, Satoshi Ohya, Takeshi Nishino
Antimicrobial Agents and Chemotherapy Feb 1999, 43 (2) 400-402; DOI: 10.1128/AAC.43.2.400
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Drug Resistance, Microbial
Pseudomonas aeruginosa
beta-lactamases

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596